Synthetic direct and indirect factor Xa inhibitors
- 1 May 2002
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 106 (3) , V267-V273
- https://doi.org/10.1016/s0049-3848(02)00080-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Antithrombotic effects of YM-60828 in three thrombosis models in guinea pigsEuropean Journal of Pharmacology, 1998
- Comparative Studies of an Orally-active Factor Xa Inhibitor, YM-60828, with other Antithrombotic Agents in a Rat Model of Arterial ThrombosisThrombosis and Haemostasis, 1998
- Biochemical and Pharmacological Characterization of YM-60828, a Newly Synthesized and Orally Active Inhibitor of Human Factor XaThrombosis and Haemostasis, 1998
- THE ANTITHROMBOTIC EFFECT OF SYNTHETIC LOW MOLECULAR WEIGHT HUMAN FACTOR Xa INHIBITOR, DX-9065a, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELSThrombosis Research, 1997
- Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitorThrombosis Research, 1995
- Antithrombotic Effects of Orally Active Synthetic Antagonist of Activated Factor X in Nonhuman PrimatesCirculation, 1995
- Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.Circulation, 1994
- A Novel Factor Xa Inhibitor: Structure-Activity Relationships and Selectivity between Factor Xa and ThrombinBiochemical and Biophysical Research Communications, 1993
- Importance of factor Xa in determining the procoagulant activity of whole-blood clots.Journal of Clinical Investigation, 1993
- Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor XaBiochemical Journal, 1989